Literature DB >> 11465908

Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.

.   

Abstract

Hepatitis B vaccination has been recommended for injection drug users (IDUs) since 1982, but vaccination coverage of IDUs remains low (1), and outbreaks of hepatitis B among IDUs continue to occur. An outbreak of hepatitis B primarily among IDUs in Pierce County, Washington, detected in April 2000, included 60 cases and resulted in three deaths among IDUs co-infected with hepatitis delta virus. A program to administer hepatitis B vaccine to IDUs was implemented to control the outbreak, and the number of cases identified decreased from 13 per month in May to two cases since November. This report describes a vaccination program during which IDUs accepted hepatitis B vaccination provided free of charge in community-based settings and illustrates how effective hepatitis B vaccination programs targeted at IDUs can be implemented through collaborations between departments of health and corrections and community organizations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465908

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  13 in total

1.  Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

Authors:  Thanh Q Tran; Carolyn Z Grimes; Dejian Lai; Catherine L Troisi; Lu-Yu Hwang
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

2.  Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

Authors:  Paula J Lum; Kristen C Ochoa; Judith A Hahn; Kimberly Page Shafer; Jennifer L Evans; Andrew R Moss
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

3.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

4.  Prevalence of Hepatitis B Virus Infection Among US Adults Aged 20-59 Years With a History of Injection Drug Use: National Health and Nutrition Examination Survey, 2001-2016.

Authors:  Jaimie Z Shing; Kathleen N Ly; Jian Xing; Eyasu H Teshale; Ruth B Jiles
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

5.  Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention.

Authors:  A R Lifson; L L Halcón
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

6.  Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

Authors:  Christopher S Murrill; Howard Weeks; Brian C Castrucci; Hillard S Weinstock; Beth P Bell; Catherine Spruill; Marta Gwinn
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

7.  Immunization programs in non-traditional settings.

Authors:  Shelagh A Weatherill; Jane A Buxton; Patricia C Daly
Journal:  Can J Public Health       Date:  2004 Mar-Apr

8.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults.

Authors:  Adeline Nyamathi; Yihang Liu; Mary Marfisee; Steven Shoptaw; Paul Gregerson; Sammy Saab; Barbara Leake; Darlene Tyler; Lillian Gelberg
Journal:  Nurs Res       Date:  2009 Jan-Feb       Impact factor: 2.381

10.  Hepatitis B vaccination and injecting drug users.

Authors:  John Budd; Roy Robertson; Rob Elton
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.